» Articles » PMID: 37296884

Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jun 10
PMID 37296884
Authors
Affiliations
Soon will be listed here.
Abstract

The association of chronic inflammation with colorectal carcinoma (CRC) development is well known in ulcerative colitis (UC). However, the role of inflammatory changes in sporadic CRC pathogenesis is less widely appreciated. In this study, in the first step using RNA-seq, we identified gene-pathway-level changes in UC-associated CRC (UC CRC, = 10) and used the changes as a proxy for inflammation in human colon to ask if there were associations of inflammatory pathway dysregulations in sporadic CRC pathogenesis ( = 8). We found down-regulations of several inflammation-related metabolic pathways (nitrogen metabolism, sulfur metabolism) and other pathways (bile secretion, fatty acid degradation) in sporadic CRC. Non-inflammation-related changes included up-regulation of the proteasome pathway. In the next step, from a larger number of paired samples from sporadic CRC patients ( = 71) from a geographically and ethnically different population and using a different platform (microarray), we asked if the inflammation-CRC association could be replicated. The associations were significant even after stratification by sex, tumor stage, grade, MSI status, and mutation status. Our findings have important implications to widen our understanding of inflammatory pathogenesis of sporadic CRC. Furthermore, targeting of several of these dysregulated pathways could provide the basis for improved therapies for CRC.

Citing Articles

Association of Microsatellite Instability and Gene Expression Profile in Colorectal Carcinoma and Potential Implications for Therapy.

Kibriya M, Jasmine F, Khamkevych Y, Raza M, Kamal M, Bissonnette M Medicina (Kaunas). 2024; 60(3).

PMID: 38541076 PMC: 10972457. DOI: 10.3390/medicina60030348.

References
1.
Lutgens M, van Oijen M, van der Heijden G, Vleggaar F, Siersema P, Oldenburg B . Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013; 19(4):789-99. DOI: 10.1097/MIB.0b013e31828029c0. View

2.
Chen T, Li Q, Wu J, Wu Y, Peng W, Li H . Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother. 2018; 67(10):1635-1646. PMC: 11028377. DOI: 10.1007/s00262-018-2233-x. View

3.
Itzkowitz S, Yio X . Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004; 287(1):G7-17. DOI: 10.1152/ajpgi.00079.2004. View

4.
Zhang H, Du W, Guo X, Wang L, Cheng J, Wei L . Identification of the AQP8-miR-92a network associated with the aggressive traits of colorectal cancer. Biochem Biophys Res Commun. 2020; 527(1):218-225. DOI: 10.1016/j.bbrc.2020.04.055. View

5.
Hsieh C, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R . Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998; 58(17):3942-5. View